Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients

Fig. 2

Analysis of OS and DFS in HCC patients by the Kaplan-Meier method. (a) OS in HCC patients by TNM stage; (b) OS in HCC patients by AFP level; (c) OS in HCC patients by ApoA-1 level; (d) OS in HCC patients by CRP level; (E) DFS in HCC patients by TNM stage; (f) DFS in HCC patients by AFP level; (g) DFS in HCC patients by ApoA-1 level; (h) DFS in HCC patients by CRP level

Back to article page